Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New protocol aims to ease bowel blockage after abdominal surgery

NCT ID NCT07194525

Symptom relief Sponsor: University of Lausanne Hospitals Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a step-by-step treatment plan called I-MAP for patients who develop a temporary bowel blockage (postoperative ileus) within 30 days after abdominal surgery. The goal was to see if the plan could be used consistently and safely. 60 adults were monitored and treated according to I-MAP, which included daily checks, contrast drinks, imaging, and medication when needed. The study did not compare I-MAP to other treatments, but focused on how well doctors could follow the protocol and whether it led to complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

May 2023

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults ≥18 years of age. * Patients who undergo abdominal surgery and develop postoperative ileus (POI) within 30 days. * Provided general consent for participation. Exclusion Criteria: * Preoperative bowel obstruction. * Anastomotic leak. * Prophylactic nasogastric tube (NGT) placement. * Pregnancy. * Lack of general consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ileus postoperative are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

paralytic ileus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ileus postoperative Nasogastric tube

Contacts and locations

Locations

  • Centre hospitalier universitaire vaudois (CHUV)

    Lausanne, Canton of Vaud, 1005, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.